RT Journal Article
SR Electronic
T1 Small RNA sequencing reveals snoRNAs and piRNA-019825 as novel players in diabetic kidney disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.05.23.22275440
DO 10.1101/2022.05.23.22275440
A1 ’t Hart, LM
A1 de Klerk, JA
A1 Bouland, GA
A1 Peerlings, JHD
A1 Blom, M.T.
A1 Cramer, SJ
A1 Bijkerk, R
A1 Beulens, JWJ
A1 Slieker, RC
YR 2024
UL http://medrxiv.org/content/early/2024/04/25/2022.05.23.22275440.abstract
AB Introduction Micro- and macrovascular complications are common among persons with type 2 diabetes. Recently there has been growing interest to investigate the potential of circulating small non-coding RNAs (sncRNAs) as contributors to the development of diabetic complications. In this study we investigate to what extent circulating sncRNAs levels associate with prevalent diabetic kidney disease (DKD) in persons with type 2 diabetes.Methods Plasma sncRNAs levels were determined using small RNA-seq, allowing detection of miRNAs, snoRNAs, piRNAs, tRNA-fragments and various other sncRNA classes. We tested for differentially expressed sncRNAs in persons with type 2 diabetes, with DKD (n=69) or without DKD (n=405). In secondary analyses, we also tested the association with eGFR, albuminuria (UACR) and the plasma proteome.Results In total seven sncRNAs were negatively associated with prevalent DKD (all PFDR≤0.05). Including one microRNA (miR-143-5p), five snoRNAs (U8, SNORD118, SNORD24, SNORD107, SNORD87) and a piRNA (piR-019825|DQ597218). Proteomic analyses showed that the seven sncRNAs, and especially the piRNA piR-019825, were associated with plasma levels of 24 proteins of which several have known associations with kidney function including TNF sR-I (TNFRFS1A), DAN (NBL1) and cystatin C (CST3).Conclusion We have identified novel small non-coding RNAs, primarily from classes other than microRNAs, that are associated with diabetic kidney disease. Our results shows that the involvement of small non-coding RNAs in DKD goes beyond the already known microRNAs and also involves other classes of sncRNA, in particular snoRNAs and the piRNA piR-019825, that have never been studied before in relation to kidney function.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a diabetes breakthrough grant from the Dutch Diabetes Research Foundation and ZonMw (grant number 459001015) and a grant from the EFSD/Boehringer Ingelheim European Research Programme on Multi-System Challenges in Diabetes 2021. The study sponsors/funders were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study has been approved by the ethics committee of the Amsterdam University Medical Center, location VUmc. All participants provided informed consent prior to this study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analyzed during the current study are not publicly available due restrictions in the informed consent but are available from the corresponding author on reasonable request.